Literature DB >> 15549209

[New aspects in uv and photochemotherapy].

M Grundmann-Kollman1, A Tanew.   

Abstract

Recent data show that from a pharmacological point of view topical (cream or bath) PUVA therapy is superior to systemic PUVA. Due to a significant reduction of side effects compared to systemic PUVA, bath PUVA has now started to replace oral PUVA therapy. Narrowband UVB has proved to be superior to broadband UVB in the treatment of psoriasis and is effective for a number of dermatoses such as vitilgo, atopic dermatitis and polymorphic light eruption. UVA1 phototherapy is highly effective in the treatment of moderate to severe atopic dermatitis and sclerosing diseases of the skin. Data dealing with UVA1 phototherapy for other indications are still preliminary. High-dose UVA1 is has been widely replaced by medium-dose UVA1, as a number of studies have shown similar therapeutic efficacy of both dose regimens.

Entities:  

Mesh:

Year:  2004        PMID: 15549209     DOI: 10.1007/s00105-004-0838-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  18 in total

1.  The time-course of psoralen ultraviolet A (PUVA) erythema.

Authors:  S H Ibbotson; P M Farr
Journal:  J Invest Dermatol       Date:  1999-09       Impact factor: 8.551

2.  The time course of phototoxicity of topical PUVA: 8-methoxypsoralen cream-PUVA vs. 8-methoxypsoralen gel-PUVA.

Authors:  M Grundmann-Kollmann; U Leiter; S Behrens; P Gottlöber; G Mooser; G Krähn; M Kerscher
Journal:  Br J Dermatol       Date:  1999-05       Impact factor: 9.302

3.  Assessment of minimal phototoxic dose following 8-methoxypsoralen bath: maximal reaction on average after 5 days.

Authors:  S Behrens-Williams; C Gruss; M Grundmann-Kollmann; R U Peter; M Kerscher
Journal:  Br J Dermatol       Date:  2000-01       Impact factor: 9.302

4.  Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.

Authors:  Irmgard Tegeder; Lutz Bräutigam; Maurizio Podda; Silke Meier; Roland Kaufmann; Gerd Geisslinger; Marcella Grundmann-Kollmann
Journal:  Clin Pharmacol Ther       Date:  2002-03       Impact factor: 6.875

5.  Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis.

Authors:  S A George; D J Bilsland; B E Johnson; J Ferguson
Journal:  Br J Dermatol       Date:  1993-01       Impact factor: 9.302

Review 6.  Photochemotherapy beyond psoriasis.

Authors:  B Honig; W L Morison; D Karp
Journal:  J Am Acad Dermatol       Date:  1994-11       Impact factor: 11.527

7.  Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study.

Authors:  A Tanew; S Radakovic-Fijan; M Schemper; H Hönigsmann
Journal:  Arch Dermatol       Date:  1999-05

8.  Long-term stability of 8-methoxypsoralen in ointments for topical PUVA therapy ('Cream-PUVA').

Authors:  J Martens-Lobenhoffer; M Rinke; D Lösche; H Gollnick
Journal:  Skin Pharmacol Appl Skin Physiol       Date:  1999 Sep-Oct

9.  Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.

Authors:  W Westerhof; L Nieuweboer-Krobotova
Journal:  Arch Dermatol       Date:  1997-12

Review 10.  Ultraviolet A1 phototherapy.

Authors:  R S Dawe
Journal:  Br J Dermatol       Date:  2003-04       Impact factor: 9.302

View more
  1 in total

1.  [Targeted UVB-308 nm (NUVB) therapy with excimer laser in the treatment of atopic dermatitis and other inflammatory dermatoses].

Authors:  I Wollenschläger; J Hermann; H M Ockenfels
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.